{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:15:42Z","timestamp":1784837742333,"version":"3.55.0"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-Young2024\\u20130036"],"award-info":[{"award-number":["Y-Young2024\\u20130036"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"publisher","award":["XYFC202404"],"award-info":[{"award-number":["XYFC202404"]}],"id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20251765"],"award-info":[{"award-number":["BK20251765"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["K2023041"],"award-info":[{"award-number":["K2023041"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drup.2026.101441","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:36:24Z","timestamp":1782862584000},"page":"101441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic analysis on epigenetic programming of tumor drug resistance"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4129-6351","authenticated-orcid":false,"given":"Xiao-Xiao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2707-9998","authenticated-orcid":false,"given":"Jia-Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fei","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Shang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-3686","authenticated-orcid":false,"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Quan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Duo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.drup.2026.101441_bib1","doi-asserted-by":"crossref","first-page":"17990","DOI":"10.1073\/pnas.1901323116","article-title":"Regulation of PRMT5-MDM4 axis is critical in the response to CDK4\/6 inhibitors in melanoma [J]","volume":"116","author":"AbuHammad","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control [J]","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"28","key":"10.1016\/j.drup.2026.101441_bib3","doi-asserted-by":"crossref","first-page":"44505","DOI":"10.18632\/oncotarget.9887","article-title":"Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer [J]","volume":"7","author":"Alzoubi","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","article-title":"Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing [J]","volume":"167","author":"Amabile","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061064","article-title":"Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer [J]","volume":"8","author":"Amir","year":"2013","journal-title":"PLoS. One"},{"issue":"49","key":"10.1016\/j.drup.2026.101441_bib6","doi-asserted-by":"crossref","first-page":"35425","DOI":"10.1074\/jbc.R700027200","article-title":"Structure and mechanism of lysine-specific demethylase enzymes [J]","volume":"282","author":"Anand","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.drup.2026.101441_bib7","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/1759-7714.15381","article-title":"METTL3\/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1 [J]","volume":"15","author":"Bai","year":"2024","journal-title":"Thorac. Cancer"},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib8","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer [J]","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"issue":"6432","key":"10.1016\/j.drup.2026.101441_bib9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1126\/science.aau5870","article-title":"Hypoxia induces rapid changes to histone methylation and reprograms chromatin [J]","volume":"363","author":"Batie","year":"2019","journal-title":"Science"},{"issue":"7546","key":"10.1016\/j.drup.2026.101441_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature14176","article-title":"Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation [J]","volume":"520","author":"Baubec","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101441_bib11","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.93194","article-title":"Evolutionary adaptation of an HP1-protein chromodomain integrates chromatin and DNA sequence signals [J]","volume":"13","author":"Baumgartner","year":"2024","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.drup.2026.101441_bib12","article-title":"Epigenetic modulation of BARD1 to enhance anti-VEGF therapy [J]","volume":"6","author":"Bayraktar","year":"2025","journal-title":"Cell. Rep. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","article-title":"Protein arginine methylation in mammals: who, what, and why [J]","volume":"33","author":"Bedford","year":"2009","journal-title":"Mol. Cell."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory [J]","volume":"16","author":"Bird","year":"2002","journal-title":"Genes. Dev."},{"issue":"3","key":"10.1016\/j.drup.2026.101441_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers [J]","volume":"21","author":"Bitler","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","article-title":"Arginine methylation: the coming of age [J]","volume":"65","author":"Blanc","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.drup.2026.101441_bib17","doi-asserted-by":"crossref","unstructured":"Blaschke K., Ebata K.T., Karimi M.M., et al.(n.d) Vitamin\u2009C induces Tet-dependent DNA demethylation and a blastocyst-lik e state in ES cells [J]. Nature, 500(7461): 222-6.","DOI":"10.1038\/nature12362"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib18","article-title":"Gastrointestinal stromal tumours [J]","volume":"7","author":"Blay","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.drup.2026.101441_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mam.2019.10.007","article-title":"Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms [J]","volume":"70","author":"Braicu","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"7","key":"10.1016\/j.drup.2026.101441_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.trecan.2020.12.011","article-title":"Roles and regulation of TET enzymes in solid tumors [J]","volume":"7","author":"Bray","year":"2021","journal-title":"Trends Cancer"},{"issue":"30","key":"10.1016\/j.drup.2026.101441_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102718118","article-title":"EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner [J]","volume":"118","author":"Bugide","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2026.101441_bib22","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.2147\/OTT.S231489","article-title":"miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer [J]","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther."},{"issue":"6432","key":"10.1016\/j.drup.2026.101441_bib23","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.aaw1026","article-title":"Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate [J]","volume":"363","author":"Chakraborty","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101441_bib24","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/ncomms6383","article-title":"The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer [J]","volume":"5","author":"Chakravarty","year":"2014","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.drup.2026.101441_bib25","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/1078-0432.CCR-24-0199","article-title":"A 5-hydroxymethylcytosine-based noninvasive model for early detection of colorectal carcinomas and advanced adenomas: the METHOD-2 Study [J]","volume":"30","author":"Chang","year":"2024","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib26","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1038\/s41467-024-53874-2","article-title":"Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer [J]","volume":"15","author":"Chatterjee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101441_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1331687","article-title":"Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells [J]","volume":"14","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drup.2026.101441_bib28","doi-asserted-by":"crossref","unstructured":"Chen K., Zhang J., Guo Z., et al.(n.d) Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylatio n in kidney cancer [J]. Cell Res, 26(1): 103-18.","DOI":"10.1038\/cr.2015.150"},{"key":"10.1016\/j.drup.2026.101441_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","article-title":"The biology of chromatin remodeling complexes [J]","volume":"78","author":"Clapier","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma [J]","volume":"346","author":"Coiffier","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib31","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2032Etudes des Lymphomes de l\u2032Adulte [J]","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.trecan.2025.01.013","article-title":"Acetylation: a new target for protein degradation in cancer [J]","volume":"11","author":"Crawford","year":"2025","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040467","article-title":"Therapy-resistant acute myeloid leukemia stem cells are resensitized to venetoclax + azacitidine by targeting fatty acid desaturases 1 and 2 [J]","volume":"13","author":"Culp-Hill","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.drup.2026.101441_bib34","doi-asserted-by":"crossref","unstructured":"Cyrus S., Burkardt D., Weaver D.D., et al.(n.d) PRC2-complex related dysfunction in overgrowth syndromes: A review of EZH2, EED, and SUZ12 and their syndromic phenotypes [J]. Am J Med Genet C Semin Med Genet, 181(4): 519-31.","DOI":"10.1002\/ajmg.c.31754"},{"key":"10.1016\/j.drup.2026.101441_bib35","article-title":"Protein arginine methylation: an emerging modification in cancer immunity and immunotherapy [J]","volume":"13","author":"Dai","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH mutations in cancer and progress toward development of targeted therapeutics [J]","volume":"27","author":"Dang","year":"2016","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/2020.02.07.931071","article-title":"DNA methylation repels binding of hypoxia-inducible transcription factors to maintain tumor immunotolerance [J]","volume":"21","author":"D'Anna","year":"2020","journal-title":"Genome Biol."},{"issue":"23","key":"10.1016\/j.drup.2026.101441_bib38","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41388-024-03054-9","article-title":"A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance [J]","volume":"43","author":"Das","year":"2024","journal-title":"Oncogene"},{"issue":"6330","key":"10.1016\/j.drup.2026.101441_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1126\/science.aam7304","article-title":"The cancer epigenome: concepts, challenges, and therapeutic opportunities [J]","volume":"355","author":"Dawson","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.drup.2026.101441_bib40","doi-asserted-by":"crossref","unstructured":"De Giglio A., Zullo L., Di Federico A., et al.(n.d) Immunotherapy beyond progression combined with platinum-based chemothe rapy after primary resistance to first-line immunotherapy in patients with advanced NSCLC and PD-L1 \u226550% [J]. ESMO Open, 10(12): 105897.","DOI":"10.1016\/j.esmoop.2025.105897"},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m(6)A modification in cancer [J]","volume":"20","author":"Deng","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.drup.2026.101441_bib42","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa2206913","article-title":"Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J]","volume":"387","author":"Dickinson","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.drup.2026.101441_bib43","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML [J]","volume":"378","author":"DiNardo","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101441_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9325407","article-title":"LncRNA PVT1 mediates antiapoptosis and 5-fluorouracil resistance via Increasing Bcl2 expression in gastric cancer [J]","volume":"2019","author":"Du","year":"2019","journal-title":"J. Oncol."},{"issue":"19","key":"10.1016\/j.drup.2026.101441_bib45","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","article-title":"The functional roles of TCA cycle metabolites in cancer [J]","volume":"40","author":"Eniafe","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2026.101441_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mattod.2023.03.006","article-title":"Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment [J]","volume":"65","author":"Erfani","year":"2023","journal-title":"Mater. Today"},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib47","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer [J]","volume":"61","author":"Esteller","year":"2001","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib48","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: A review [J]","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib49","first-page":"627","article-title":"LncRNA MALAT1 promotes lung cancer proliferation and gefitinib resistance by acting as a miR-200a Sponge [J]","volume":"55","author":"Feng","year":"2019","journal-title":"Arch. Bronconeumol. (Engl. Ed."},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.trecan.2025.04.004","article-title":"Tissue mechanics in tumor heterogeneity and aggression [J]","volume":"11","author":"Finger","year":"2025","journal-title":"Trends Cancer"},{"issue":"6348","key":"10.1016\/j.drup.2026.101441_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer [J]","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"issue":"6538","key":"10.1016\/j.drup.2026.101441_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.abb4542","article-title":"Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors [J]","volume":"372","author":"Fugger","year":"2021","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.drup.2026.101441_bib53","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/0008-5472.CAN-18-2052","article-title":"Epithelial-to-mesenchymal transition is a mechanism of ALK inhibitor resistance in lung cancer independent of ALK Mutation Status [J]","volume":"79","author":"Fukuda","year":"2019","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.drup.2026.101441_bib54","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.trecan.2024.08.005","article-title":"Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes [J]","volume":"10","author":"Gantner","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.drup.2026.101441_bib55","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.steroids.2014.12.021","article-title":"CYP17A1 inhibitors in castration-resistant prostate cancer [J]","volume":"95","author":"Gomez","year":"2015","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41419-022-05406-3","article-title":"Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC\/PCAF\/AKT axis [J]","volume":"14","author":"Guo","year":"2023","journal-title":"Cell. death & Dis."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-025-01883-y","article-title":"MiRNA-21 promotes the migration and proliferation of prostate cancer cells via activating the JAK\/STAT pathway [J]","volume":"16","author":"Han","year":"2025","journal-title":"Discov. Onc"},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib58","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s10120-021-01206-4","article-title":"Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance [J]","volume":"24","author":"Harada","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.drup.2026.101441_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1728091","article-title":"Epigenetic control of antigen presentation failure in osteosarcoma: from single-cell chromatin maps to therapeutic strategies [J]","volume":"16","author":"He","year":"2025","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.drup.2026.101441_bib60","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40265-020-01288-x","article-title":"Tazemetostat: First Approval [J]","volume":"80","author":"Hoy","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.drup.2026.101441_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2025.110074","article-title":"Lysine beta-hydroxybutyrylation in metabolic plasticity and disease pathogenesis [J]","volume":"146","author":"Hu","year":"2025","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.drup.2026.101441_bib62","article-title":"PRMT5 inhibition promotes PD-L1 expression and immuno-resistance in lung cancer [J]","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00018-024-05320-1","article-title":"Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer [J]","volume":"81","author":"Huang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"22","key":"10.1016\/j.drup.2026.101441_bib64","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes [J]","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101441_bib65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2019.12.010","article-title":"ATP citrate lyase: a central metabolic enzyme in cancer [J]","volume":"471","author":"Icard","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2026.101441_bib66","doi-asserted-by":"crossref","unstructured":"Jazieh K., Tsai J., Solomon S., et al.(n.d) Identification of candidate alterations mediating KRAS G12C inhibitor resistance in advanced colorectal and pancreatic cancers [J]. Clinical Cancer Research, 31(5): 899-906.","DOI":"10.1158\/1078-0432.CCR-24-2948"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-026-01240-3","article-title":"Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities [J]","volume":"33","author":"Jeong","year":"2026","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-Dependent Lymphomas [J]","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2026.101441_bib69","doi-asserted-by":"crossref","unstructured":"Jittikoon J., Saengsiwaritt W., Chanhom N., et al.(n.d) Association of NAT2 promoter hypermethylation with susceptibility to h epatotoxicity due to antituberculosis drugs and biomarker potential [J]. Scientific reports, 15(1): 10197.","DOI":"10.1038\/s41598-025-95050-6"},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib70","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy [J]","volume":"17","author":"Jones","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11883-020-00872-6","article-title":"The long non-coding road to atherosclerosis [J]","volume":"22","author":"Josefs","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"issue":"22","key":"10.1016\/j.drup.2026.101441_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212387","article-title":"Oxidative Stress and Cancer Therapy: Controlling Cancer Cells Using Reactive Oxygen Species [J]","volume":"25","author":"Ju","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.drup.2026.101441_bib73","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/eji.201141931","article-title":"Reduced tumor-antigen density leads to PD-1\/PD-L1-mediated impairment of partially exhausted CD8\u207a T cells [J]","volume":"42","author":"Kaiser","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.drup.2026.101441_bib74","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41568-022-00503-z","article-title":"Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation [J]","volume":"22","author":"Kandalaft","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib75","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-01026-6","article-title":"The management of metastatic GIST: current standard and investigational therapeutics [J]","volume":"14","author":"Kelly","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101441_bib76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cca.2018.11.018","article-title":"Long interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer [J]","volume":"488","author":"Kerachian","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"28","key":"10.1016\/j.drup.2026.101441_bib77","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.0904715106","article-title":"Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression [J]","volume":"106","author":"Khalil","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"645","key":"10.1016\/j.drup.2026.101441_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aba8091","article-title":"Degradation of 5hmC-marked stalled replication forks by APE1 causes genomic instability [J]","volume":"13","author":"Kharat","year":"2020","journal-title":"Sci. Signal."},{"issue":"7","key":"10.1016\/j.drup.2026.101441_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110393","article-title":"5hmC enhances PARP trapping and restores PARP inhibitor sensitivity in chemoresistant BRCA1\/2-deficient cells [J]","volume":"301","author":"Kharat","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib80","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ccr.2013.04.008","article-title":"Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells [J]","volume":"23","author":"Kim","year":"2013","journal-title":"Cancer Cell."},{"issue":"7","key":"10.1016\/j.drup.2026.101441_bib81","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s12276-022-00812-1","article-title":"Gene regulation by histone-modifying enzymes under hypoxic conditions: a focus on histone methylation and acetylation [J]","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib82","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer [J]","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.drup.2026.101441_bib83","doi-asserted-by":"crossref","unstructured":"Kohli R.M., Zhang Y..(n.d) TET enzymes, TDG and the dynamics of DNA demethylation [J]. Nature, 502(7472): 472-9.","DOI":"10.1038\/nature12750"},{"issue":"5","key":"10.1016\/j.drup.2026.101441_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050810","article-title":"Targeting autophagy using long non-coding RNAs (LncRNAs): new landscapes in the arena of cancer therapeutics [J]","volume":"12","author":"Kumar","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib85","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/s41467-019-12194-6","article-title":"Caspase-10 inhibits ATP-citrate lyase-mediated metabolic and epigenetic reprogramming to suppress tumorigenesis [J]","volume":"10","author":"Kumari","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.drup.2026.101441_bib86","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","article-title":"Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability-high gastric cancer [J]","volume":"11","author":"Kwon","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molcel.2019.03.011","article-title":"Molecular mechanisms directing PRC2 recruitment and H3K27 methylation [J]","volume":"74","author":"Laugesen","year":"2019","journal-title":"Mol. Cell."},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib88","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1242\/dev.122.10.3195","article-title":"De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells [J]","volume":"122","author":"Lei","year":"1996","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib89","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(92)90611-F","article-title":"Targeted mutation of the DNA methyltransferase gene results in embryonic lethality [J]","volume":"69","author":"Li","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.drup.2026.101441_bib90","doi-asserted-by":"crossref","unstructured":"Li J., Hu J., Yang Y., et al.(n.d) Drug resistance in cancer: molecular mechanisms and emerging treatment strategies [J]. Mol Biomed, 6(1).","DOI":"10.1186\/s43556-025-00352-w"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib91","article-title":"5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies [J]","volume":"5","author":"Li","year":"2025","journal-title":"Commun. Med. -Lond."},{"issue":"18","key":"10.1016\/j.drup.2026.101441_bib92","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.7150\/jca.56093","article-title":"HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer [J]","volume":"12","author":"Li","year":"2021","journal-title":"J. Cancer"},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib93","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy [J]","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-024-01024-9","article-title":"CancerGPT for few shot drug pair synergy prediction using large pretrained language models [J]","volume":"7","author":"Li","year":"2024","journal-title":"Npj Digit. Med."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib95","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma [J]","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2026.101441_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215904","article-title":"KIF17 maintains the epithelial phenotype of breast cancer cells and curbs tumour metastasis [J]","volume":"548","author":"Li","year":"2022","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib97","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/s41388-022-02213-0","article-title":"Active demethylation upregulates CD147 expression promoting non-small cell lung cancer invasion and metastasis [J]","volume":"41","author":"Liao","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41467-022-35710-7","article-title":"Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation [J]","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.drup.2026.101441_bib99","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","article-title":"Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non-small cell lung cancer [J]","volume":"83","author":"Lin","year":"2023","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.molcel.2013.07.002","article-title":"Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth [J]","volume":"51","author":"Lin","year":"2013","journal-title":"Mol. Cell."},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib101","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/neuonc\/noaf055","article-title":"Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy [J]","volume":"27","author":"Lin","year":"2025","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2013.07.022","article-title":"Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification [J]","volume":"339","author":"Liu","year":"2013","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib103","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics [J]","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.drup.2026.101441_bib104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ni.3796","article-title":"\u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming [J]","volume":"18","author":"Liu","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","article-title":"Editing DNA Methylation in the Mammalian Genome [J]","volume":"167","author":"Liu","year":"2016","journal-title":"Cell"},{"issue":"348","key":"10.1016\/j.drup.2026.101441_bib106","doi-asserted-by":"crossref","first-page":"348ra97","DOI":"10.1126\/scitranslmed.aaf3124","article-title":"Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin [J]","volume":"8","author":"Liu","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"46","key":"10.1016\/j.drup.2026.101441_bib107","article-title":"Lactylation-Driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC [J]","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib108","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-022-02539-5","article-title":"The molecular mechanism of METTL3 promoting the malignant progression of lung cancer [J]","volume":"22","author":"Ma","year":"2022","journal-title":"Cancer Cell. Int."},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib109","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s43018-022-00405-x","article-title":"Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1 [J]","volume":"3","author":"Mabe","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2026.101441_bib110","doi-asserted-by":"crossref","unstructured":"MacArthur I.C., Ma L., Huang C.-Y., et al.(n.d) Developmental DNA demethylation is a determinant of neural stem cell i dentity and gliogenic competence [J]. Sci Adv, 10(35).","DOI":"10.1126\/sciadv.ado5424"},{"issue":"3","key":"10.1016\/j.drup.2026.101441_bib111","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lungcan.2015.01.009","article-title":"CpG hypermethylation contributes to decreased expression of PTEN during acquired resistance to gefitinib in human lung cancer cell lines [J]","volume":"87","author":"Maeda","year":"2015","journal-title":"Lung Cancer"},{"issue":"17","key":"10.1016\/j.drup.2026.101441_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26178132","article-title":"Unraveling the epigenetic landscape of mature B cell neoplasia: mechanisms, biomarkers, and therapeutic opportunities [J]","volume":"26","author":"Maher","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.drup.2026.101441_bib113","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012744","article-title":"m(6)A-driven transcriptomic rewiring in tumor immune surveillance [J]","volume":"13","author":"Malvi","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113124","article-title":"Perturbations in 3D genome organization can promote acquired drug resistance [J]","volume":"42","author":"Manjon","year":"2023","journal-title":"Cell. Rep."},{"issue":"5","key":"10.1016\/j.drup.2026.101441_bib115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.32604\/or.2022.026913","article-title":"Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas [J]","volume":"30","author":"Manta","year":"2022","journal-title":"Oncol. Res."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115064","article-title":"Metabolic reprogramming, sensing, and cancer therapy [J]","volume":"43","author":"Mao","year":"2024","journal-title":"Cell. Rep."},{"issue":"11","key":"10.1016\/j.drup.2026.101441_bib117","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome [J]","volume":"361","author":"Mardis","year":"2009","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.drup.2026.101441_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2020.03.001","article-title":"mTOR complex 2 is an integrator of cancer metabolism and epigenetics [J]","volume":"478","author":"Masui","year":"2020","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib119","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","article-title":"Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective [J]","volume":"187","author":"Mathur","year":"2024","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib120","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations [J]","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"15","key":"10.1016\/j.drup.2026.101441_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153862","article-title":"HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer [J]","volume":"13","author":"Mayr","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2026.101441_bib122","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.acr.2018.02.006","article-title":"Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics [J]","volume":"138","author":"McClure","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.drup.2026.101441_bib123","first-page":"46","article-title":"HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond [J]","volume":"7","author":"Minisini","year":"2024","journal-title":"Cancer Drug. Resist."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-019-0267-4","article-title":"Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise [J]","volume":"17","author":"Morel","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin [J]","volume":"42","author":"Morin","year":"2010","journal-title":"Nat. Genet."},{"issue":"7360","key":"10.1016\/j.drup.2026.101441_bib126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma [J]","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.drup.2026.101441_bib127","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","article-title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial [J]","volume":"21","author":"Morschhauser","year":"2020","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113273","article-title":"m(6)A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1\u03b1 activation [J]","volume":"42","author":"Nan","year":"2023","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drup.2026.101441_bib129","unstructured":"Ng C.X., Lee S.Y., Yap X.Y., et al.(n.d) Epigenetic reprogramming as the nexus of cancer stemness and therapy r esistance: implications for biomarker discovery [J]. Discov Onc."},{"issue":"11","key":"10.1016\/j.drup.2026.101441_bib130","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer [J]","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized Management of Pheochromocytoma and Paraganglioma [J]","volume":"43","author":"Nolting","year":"2022","journal-title":"Endocr. Rev."},{"issue":"27","key":"10.1016\/j.drup.2026.101441_bib132","doi-asserted-by":"crossref","first-page":"18668","DOI":"10.1074\/jbc.M512454200","article-title":"A requirement for dimerization of HP1Hsalpha in suppression of breast cancer invasion [J]","volume":"281","author":"Norwood","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101441_bib133","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation [J]","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib134","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.semcdb.2012.01.013","article-title":"Alterations of metabolic genes and metabolites in cancer [J]","volume":"23","author":"Oermann","year":"2012","journal-title":"Semin. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.drup.2026.101441_bib135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2011.09.012","article-title":"Oxidative damage targets complexes containing DNA Methyltransferases, SIRT1, and Polycomb Members to Promoter CpG Islands [J]","volume":"20","author":"O'Hagan","year":"2011","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drup.2026.101441_bib136","doi-asserted-by":"crossref","unstructured":"Okano M., Bell D.W., Haber D.A., et al.(n.d) DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Met hylation and Mammalian Development [J]. Cell, 99(3): 247-57.","DOI":"10.1016\/S0092-8674(00)81656-6"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib137","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73624-w","article-title":"M1 Macrophage and M1\/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer [J]","volume":"10","author":"Oshi","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.drup.2026.101441_bib138","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.cmet.2025.03.004","article-title":"Gang of 3: how the Krebs cycle-linked metabolites itaconate, succinate, and fumarate regulate macrophages and inflammation [J]","volume":"37","author":"P\u00e5lsson-McDermott","year":"2025","journal-title":"Cell. Metab."},{"issue":"9","key":"10.1016\/j.drup.2026.101441_bib139","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/1878-0261.13180","article-title":"Autophagy inhibits cancer stemness in triple-negative breast cancer via miR-181a-mediated regulation of ATG5 and\/or ATG2B [J]","volume":"16","author":"Park","year":"2022","journal-title":"Mol. Oncol."},{"issue":"5897","key":"10.1016\/j.drup.2026.101441_bib140","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme [J]","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"issue":"7337","key":"10.1016\/j.drup.2026.101441_bib141","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma [J]","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.drup.2026.101441_bib142","doi-asserted-by":"crossref","unstructured":"Pastor W.A., Aravind L., Rao A..(n.d) TETonic shift: biological roles of TET proteins in DNA demethylation a nd transcription [J]. Nat Rev Mol Cell Biol, 14(6): 341-56.","DOI":"10.1038\/nrm3589"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib143","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13148-018-0527-7","article-title":"Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer [J]","volume":"10","author":"Peng","year":"2018","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib144","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s12672-025-03258-9","article-title":"Advances in the regulation of macrophage polarization by the tumor microenvironment [J]","volume":"16","author":"Peng","year":"2025","journal-title":"Discov. Oncol."},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment [J]","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib146","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1139\/bcb-2019-0045","article-title":"The impact of epigenetics on cardiovascular disease [J]","volume":"98","author":"Prasher","year":"2020","journal-title":"Biochem. Cell. Biol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib147","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41576-022-00509-1","article-title":"Characterizing cis-regulatory elements using single-cell epigenomics [J]","volume":"24","author":"Preissl","year":"2023","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"10.1016\/j.drup.2026.101441_bib148","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neo.2014.09.001","article-title":"The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc [J]","volume":"16","author":"Prensner","year":"2014","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib149","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/0008-5472.CAN-13-3159","article-title":"PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer [J]","volume":"74","author":"Prensner","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2026.101441_bib150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1476-4598-8-85","article-title":"HIPK2 modulates p53 activity towards pro-apoptotic transcription [J]","volume":"8","author":"Puca","year":"2009","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib151","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2017.09.006","article-title":"CRISPR\/Cas9-Based Engineering of the Epigenome [J]","volume":"21","author":"Pulecio","year":"2017","journal-title":"Cell. Stem Cell."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib152","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","article-title":"Methyltransferase-like proteins in cancer biology and potential therapeutic targeting [J]","volume":"16","author":"Qi","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2026.101441_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111076","article-title":"Crosstalk between m6A modification and non-coding RNAs in HCC [J]","volume":"117","author":"Qiu","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.drup.2026.101441_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy [J]","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib155","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-024-03218-6","article-title":"DNA methylation patterns of transcription factor binding regions characterize their functional and evolutionary contexts [J]","volume":"25","author":"Rimoldi","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2026.101441_bib156","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.omtn.2021.04.021","article-title":"Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers [J]","volume":"25","author":"Rong","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib157","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1074\/jbc.M109.021824","article-title":"Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein\/p300 [J]","volume":"285","author":"Ruas","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2026.101441_bib158","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2019.07.017","article-title":"Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression [J]","volume":"65","author":"Saleh","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib159","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1038\/s41598-018-23714-7","article-title":"Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression [J]","volume":"8","author":"Sant","year":"2018","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.drup.2026.101441_bib160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.195385","article-title":"Methylation-induced suppression of YAP\/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomas [J]","volume":"10","author":"Sears","year":"2025","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib161","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.19.00172","article-title":"Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J]","volume":"38","author":"Sehn","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib162","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations [J]","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.drup.2026.101441_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.65","article-title":"Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells [J]","volume":"7","author":"Shenoy","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.drup.2026.101441_bib164","doi-asserted-by":"crossref","unstructured":"Shim E.-H., Livi C.B., Rakheja D., et al.(n.d) L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometaboli te in renal cancer [J]. Cancer discovery, 4(11): 1290-8.","DOI":"10.1158\/2159-8290.CD-13-0696"},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib165","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1007\/s12035-024-04074-y","article-title":"Long Non-coding RNA ANRIL and its role in the development of age-related diseases [J]","volume":"61","author":"Shou","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188967","article-title":"20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight [J]","volume":"1878","author":"Singh","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib167","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","article-title":"Nuclear Acetyl-CoA Production by ACLY promotes homologous recombination [J]","volume":"67","author":"Sivanand","year":"2017","journal-title":"Mol. Cell."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib168","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500857R","article-title":"Epigenetic Regulation of PEPT2 as a novel strategy to improve the antitumor efficacy of lenalidomide in clear cell renal cell carcinoma [J]","volume":"39","author":"Song","year":"2025","journal-title":"Faseb J."},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib169","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41568-025-00824-9","article-title":"Acquired resistance in cancer: towards targeted therapeutic strategies [J]","volume":"25","author":"Soragni","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib170","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899242","article-title":"SUMOylation coordinates BERosome assembly in active DNA demethylation during cell differentiation [J]","volume":"38","author":"Steinacher","year":"2019","journal-title":"EMBO J."},{"issue":"13","key":"10.1016\/j.drup.2026.101441_bib171","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1158\/0008-5472.CAN-10-4111","article-title":"HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer [J]","volume":"71","author":"Stronach","year":"2011","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib172","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pccm.2022.10.001","article-title":"Taking early preventive interventions to manage the challenging issue of acquired resistance to third-generation EGFR inhibitors [J]","volume":"1","author":"Sun","year":"2023","journal-title":"Chin. Med. J. Pulm. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib173","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer [J]","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell."},{"key":"10.1016\/j.drup.2026.101441_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112156","article-title":"METTL3 contributes to osimertinib resistance in non-small cell lung cancer cell lines by regulating CDC25A and AURKB mRNA stability [J]","volume":"136","author":"Suzuki","year":"2025","journal-title":"Cell. Signal."},{"issue":"20","key":"10.1016\/j.drup.2026.101441_bib175","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms [J]","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib176","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1038\/s41467-021-25624-1","article-title":"Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse [J]","volume":"12","author":"Taavitsainen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2026.101441_bib177","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1672524","article-title":"Epigenetic mechanisms of drug resistance in acute myeloid leukemia: advances in small-molecule targeted therapy [J]","volume":"16","author":"Tang","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.drup.2026.101441_bib178","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00018-019-03145-x","article-title":"Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level [J]","volume":"76","author":"Tewary","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib179","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41408-024-00997-w","article-title":"Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas [J]","volume":"14","author":"Trabolsi","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.drup.2026.101441_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2026.101350","article-title":"Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance [J]","volume":"85","author":"Trnkova","year":"2026","journal-title":"Drug. Resist. Updat."},{"issue":"5","key":"10.1016\/j.drup.2026.101441_bib181","doi-asserted-by":"crossref","first-page":"643","DOI":"10.5858\/arpa.2018-0024-RS","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma [J]","volume":"143","author":"Tsai","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib182","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41416-023-02412-w","article-title":"Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism [J]","volume":"129","author":"Valcarcel-Jimenez","year":"2023","journal-title":"Brit J. Cancer"},{"issue":"9","key":"10.1016\/j.drup.2026.101441_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109202","article-title":"Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition [J]","volume":"35","author":"Vander Linden","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drup.2026.101441_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1156120","article-title":"Regulation of SPDEF expression by DNA methylation in advanced prostate cancer [J]","volume":"14","author":"Vatanmakanian","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.drup.2026.101441_bib185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.005","article-title":"Epigenetic remodelling under hypoxia [J]","volume":"98","author":"Verdikt","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2026.101441_bib186","series-title":"Oncoimmunology: A Practical Guide for Cancer Immunotherapy","first-page":"23","article-title":"CD8+ T Cells in Immunotherapy, Radiotherapy, and Chemotherapy [M]\/\/ZITVOGEL L, KROEMER G","author":"Wang","year":"2018"},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib187","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41388-019-1065-2","article-title":"HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer [J]","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib188","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.328","article-title":"Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms [J]","volume":"7","author":"Wang","year":"2016","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.drup.2026.101441_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125690","article-title":"Quantitative investigation of the effects of DNA modifications and protein mutations on MeCP2-MBD-DNA interactions [J]","volume":"247","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","article-title":"Targeting epigenetic regulators to overcome drug resistance in cancers [J]","volume":"8","author":"Wang","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.drup.2026.101441_bib191","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41419-024-06951-9","article-title":"Chemotherapy-induced acetylation of ACLY by NAT10 promotes its nuclear accumulation and acetyl-CoA production to drive chemoresistance in hepatocellular carcinoma [J]","volume":"15","author":"Wang","year":"2024","journal-title":"Cell. Death Dis."},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116314","article-title":"ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy [J]","volume":"44","author":"Wang","year":"2025","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drup.2026.101441_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115477","article-title":"N6-methyladenosine (m6A) in cancer therapeutic resistance: potential mechanisms and clinical implications [J]","volume":"167","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drup.2026.101441_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216612","article-title":"Targeting IL-6\/STAT3 signaling abrogates EGFR-TKI resistance through inhibiting Beclin-1 dependent autophagy in HNSCC [J]","volume":"586","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.drup.2026.101441_bib195","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/hmg\/ddt614","article-title":"Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype [J]","volume":"23","author":"Watson","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib196","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.47","article-title":"SUV39H1\/H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells [J]","volume":"3","author":"Watson","year":"2014","journal-title":"Oncogenesis"},{"issue":"4","key":"10.1016\/j.drup.2026.101441_bib197","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2010.09.006","article-title":"Epigenetic antagonism between polycomb and SWI\/SNF complexes during oncogenic transformation [J]","volume":"18","author":"Wilson","year":"2010","journal-title":"Cancer Cell."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib198","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor [J]","volume":"77","author":"Wu","year":"2020","journal-title":"Mol. Cell."},{"key":"10.1016\/j.drup.2026.101441_bib199","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.704341","article-title":"NAT10-Mediated N4-Acetylcytidine of RNA contributes to post-transcriptional regulation of mouse oocyte maturation in vitro [J]","volume":"9","author":"Xiang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"6","key":"10.1016\/j.drup.2026.101441_bib200","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jpha.2023.04.009","article-title":"Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer [J]","volume":"13","author":"Xiao","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.drup.2026.101441_bib201","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1441222","article-title":"Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer [J]","volume":"14","author":"Xie","year":"2024","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.drup.2026.101441_bib202","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","article-title":"Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells [J]","volume":"82","author":"Xiong","year":"2022","journal-title":"Mol. Cell."},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib203","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tig.2025.05.005","article-title":"Epigenetic regulation in early embryo development: from zygotic genome activation to the first lineage specification [J]","volume":"41","author":"Xu","year":"2025","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cas.15590","article-title":"METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer [J]","volume":"114","author":"Xu","year":"2023","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.drup.2026.101441_bib205","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41416-019-0625-0","article-title":"HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer [J]","volume":"121","author":"Xue","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"7464","key":"10.1016\/j.drup.2026.101441_bib206","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nature12451","article-title":"lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs [J]","volume":"500","author":"Yang","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.drup.2026.101441_bib207","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/15384101.2022.2122257","article-title":"The role of SET domain containing lysine methyltransferase 7 in tumorigenesis and development [J]","volume":"22","author":"Yang","year":"2023","journal-title":"Cell. Cycle"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib208","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-020-01682-z","article-title":"Histone methyltransferase and drug resistance in cancers [J]","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib209","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.trecan.2017.12.005","article-title":"Metabolism, activity, and targeting of D- and L-2-Hydroxyglutarates [J]","volume":"4","author":"Ye","year":"2018","journal-title":"Trends Cancer"},{"issue":"11-12","key":"10.1016\/j.drup.2026.101441_bib210","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10495-022-01751-y","article-title":"The histone deacetylase SIRT6 promotes glycolysis through the HIF-1\u03b1\/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer [J]","volume":"27","author":"You","year":"2022","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib211","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13059-021-02308-z","article-title":"Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma [J]","volume":"22","author":"Yu","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.drup.2026.101441_bib212","article-title":"Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis [J]","volume":"164","author":"Yuan","year":"2023","journal-title":"Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"key":"10.1016\/j.drup.2026.101441_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106582","article-title":"Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: biological functions and therapeutic perspectives [J]","volume":"187","author":"Zandieh","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.drup.2026.101441_bib214","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/IGC.0b013e318207dac7","article-title":"Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression [J]","volume":"21","author":"Zhang","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.drup.2026.101441_bib215","article-title":"Metabolism and epigenetics in cancer: toward personalized treatment [J]","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"7779","key":"10.1016\/j.drup.2026.101441_bib216","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation [J]","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.drup.2026.101441_bib217","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.7150\/jca.30877","article-title":"Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance [J]","volume":"10","author":"Zhao","year":"2019","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.drup.2026.101441_bib218","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13059-019-1870-5","article-title":"Epigenetic modifications of histones in cancer [J]","volume":"20","author":"Zhao","year":"2019","journal-title":"Genome Biol."},{"issue":"13","key":"10.1016\/j.drup.2026.101441_bib219","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1021\/acs.jmedchem.3c00250","article-title":"Targeting arginine methyltransferase PRMT5 for cancer therapy: updated progress and novel strategies [J]","volume":"66","author":"Zheng","year":"2023","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.drup.2026.101441_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.04.002","article-title":"Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis [J]","volume":"187","author":"Zong","year":"2024","journal-title":"Cell"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764626000920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:48:54Z","timestamp":1784836134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764626000920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":220,"alternative-id":["S1368764626000920"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2026.101441","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic analysis on epigenetic programming of tumor drug resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2026.101441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101441"}}